Risk factors
Dyne Therapeutics (DYN) risk factors
Item 1A of every Dyne Therapeutics, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors74 risks6 new2 dropped15 reworded
Cash of $1.1 billion is expected to fund operations only through the first quarter of 2028, creating near-term financing risk.
Filed Mar 02, 2026 - FY2024 10-K risk factors100 risks
Clinical failure, patient recruitment, and the unproven FORCE platform dominate risks to DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
Filed Feb 27, 2025